Predictor of Early Remission of Diabetic Macular Edema under As-Needed Intravitreal Ranibizumab
Abstract The early remission of diabetic macular edema (DME) often occurs in eyes treated with anti-vascular endothelial growth factor (VEGF) treatment. We retrospectively reviewed and characterized eyes with early remission of DME at six months in 80 eyes under pro re nata (PRN) intravitreal ranibi...
Enregistré dans:
Auteurs principaux: | Tatsuya Yoshitake, Tomoaki Murakami, Kiyoshi Suzuma, Masahiro Fujimoto, Yoko Dodo, Akitaka Tsujikawa |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/4e45db775cc64c1a91f4546776fa7729 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Clinical relevance of reduced decorrelation signals in the diabetic inner choroid on optical coherence tomography angiography
par: Yoko Dodo, et autres
Publié: (2017) -
Diabetic papillopathy with macular edema treated with intravitreal ranibizumab
par: Kim M, et autres
Publié: (2013) -
Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
par: Fouda SM, et autres
Publié: (2017) -
Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
par: Pessoa B, et autres
Publié: (2021) -
Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
par: Thomas BJ, et autres
Publié: (2016)